OP Asset Management’s Akero Therapeutics AKRO Stock Holding History

OP Asset Management’s Portfolio AKRO Stock Details AKRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-8,106	Closed	-$385K	–	779
2025 Q3	$385K	Sell	8,106 -655	-7%	-$31.7K	﹤0.01%	692
2025 Q2	$467K	Buy	+8,761	New	+$398K	0.01%	677

Other funds holding AKRO

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

OP Asset Management's AKRO Position: Q4 2025 in Review

OP Asset Management sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 8,106 shares — an estimated $385K sold.

OP Asset Management first reported a position in AKRO in Q2 2025 and held it in 2 quarters. The position peaked at $467K in Q2 2025. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

OP Asset Management reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
OP Asset Management sold 8,106 Akero Therapeutics shares in Q4 2025, an estimated $385K.
OP Asset Management first reported a position in Akero Therapeutics in Q2 2025 and held it in 2 quarters.
OP Asset Management's Akero Therapeutics position peaked at $467K in Q2 2025.
2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on OP Asset Management's 13F filing for Q4 2025, filed 21 Apr 2026.